**ABSTRACT**

***Background:*** Although electroconvulsive therapy (ECT) is regarded as one of the efficient treatments for intractable psychiatric disorders, the mechanism of therapeutic action remains unclear. Recently, many studies indicate that ECT affects the immune system, including the immune-related cells, such as microglia, astrocytes, and lymphocytes. Moreover, microglial and astrocytic activation has been implicated in postmortem brains of schizophrenia patients. We previously demonstrated that Gunn rats showed schizophrenia-like behavior and microglial activation in their brains. In this study we examined the effects of electroconvulsive shock (ECS), an animal counterpart of ECT, on schizophrenia-like behavior, microgliosis and astrogliosis in the hippocampus of Gunn rats.

***Methods:*** The rats were divided into 4 groups, i.e., Wistar sham, Wistar ECS, Gunn sham and Gunn ECS. ECS groups received ECS once daily for 6 consecutive days. Subsequently, prepulse inhibition test (PPI) was performed on all animals. After PPI, immunohistochemistry analysis was carried out to determine microglial activation and astrocytic activation, using anti-CD11b and anti-GFAP antibody, respectively.

***Results:*** We found PPI deficit in Gunn rats compared to Wistar rats, and it was significantly improved by ECS. In immunohistochemistry analysis revealed that there is significant higher expression of CD11b and GFAP in Gunn rats compared to Wistar rats. ECS attenuated the expression of both CD11b and GFAP in Gunn rats. The effect of ECS on the number of microglia in the hippocampus will be shown in the poster presentation.

***Conclusion:*** Our findings indicate that ECS ameliorates schizophrenia-like behavior in Gunn rats and attenuates both microglial activation and astrocytic activation in the hippocampus of Gunn rats. Accordingly, therapeutic effects of ECT may be exerted, at least in part, by inhibition of glial activation.
